slaoui. if you've been following it all, the russian data from -- with regarding to the sputnik vaccine, which i know they haven't accrued that much, but it looks relatively promising, i wonder if you have any thoughts regarding that and whether that could ever be a possibility for the u.s. and the second part of the question, do you expect all three million nursing home residents and most health care to be vaccinated by the end of thyear -- end of this ye? dr. slaoui: so regarding the question, very scarce access to any data. only whatever is in the public domain. the one thing i would comment on is that the vector used, which is human adenovirus 5 has been associated in hiv connected trials with an increased susceptivity to acquiring. so a word of caution as to exactly what kind of molecular engineering might have been done on their vector to avoid what should obviously be avoided, which is increased susceptibility to acquiring hiv. i believe it was in the male population. as regard to the

slow by -- slaoui for a revufmente dr. slaoui: briefly, first, of course -- slaoui for a review. of la we: briefly, first, course, as you could see i hope you had a chance to attend parts if not all of those conversations. efficacy and safety were, frankly, overwhelmingly positive. so was the vote. positive votes. the only point of discussion that took place was in regard f what to do for the placebo recipients in the trial should they be kept on placebo? should they be provided vaccine on the basis of priority populations as various risk populations are offered vaccine in the general population? or should they all be offered vaccine? what's at stake is how much more information can be extracted from a placebo-controlled part of the trial versus a nonplacebo control part of the trial. i'll be happy to address any questions you have in that regard. it is also the start of a trial in population age 12 to 18 to enhance the label and expand the using the population. ecause of the greatness of that vaccine there is considerations on those sparing trials to see if there is a lower dose

slaoui. as the general said, we should have 20 million doses to allocate for distribution by the end of this year. and of course that also has 20 million of the second dose, the booster shot is in reserve. so that that's there and available for individuals. then we think that by the end of january, we would have had the capacity for 50 million individuals to have been vaccinated with the first dose. and then going into february, by the end of february, we believe just with the moderna and pfizer vaccines, that we would have enough vaccine that 100 million shots in arms could have been delivered between first and booster shot. if you add the j&j and/or astrazeneca vaccines in, assuming approval sometime in late january, you could significantly enhance those numbers going into february. so that's why i said it seems realistic that the end of february into the first several weeks of march we could be seeing more generalized vaccination programs beyond a lot of prioritized groups. and what we hav

moncef slaoui.tor, i want to begin by saying congratulations to you and your team for this remarkable accomplishment. >> dr. slaoui: good morning, chris, and thank you for having me and thank you for your nice words. of course thousands and tens of thousands of people have participated to this first critical milestone. want to congratulate pfizer and [indiscernible], were really the key players in delivering this vaccine and it's a very good day for america and for the world. >> chris: want to ask you questions about both the short-term and the long-term. how long before your first two top priority groups, health care workers on the front line and nursing home residents, before they are fully vaccinated, get both of their doses of the pfizer vaccine? >> dr. slaoui: so we plan to have about 14 million doses of vaccine available to us and distributed in the u.s. by the end of this year, so by the end of december. those would be both pfizer vaccine and the moderna vaccine in the next month we will have

slaoui. i want to talk about three things. allocation update, our distribution and support of the state plans, our ability to empower them, to execute their plans, and then third, just to reinforce the challenge -- my word -- to secretary azar's comments at the end about learning about vaccines. so, you know, first reference, allocations. we have provided the 64 jurisdictions, which as a reminder is 50 states, eight territories and six mega cities as well as five federal agencies with their allocations of the vaccines that are going to be available in the month of december. what we've done is, we believe for planning purposes only we had to pick a day, and i've coined the phrase snap the chalk line so we could plan on actual doses that would be available. so, for example, a week and a half ago, around 20 november through tiberius, we identified the four areas of the 4 million doses that will be available. a week later on 27 november, we provided the 64 jurisdictions and five federal agencies,

slaoui: if we talk about vaccination, every year in the u.s. between 80 million and 100 million of doses of flu vaccines are distributed. and therefore we are talking about something that's maybe hree or four times bigger. over a period that's probably similar, six months, because the flu vaccines are distributed from the month of august to the month of december. i would say the distribution aspect and the immunization aspect i think are not very significantly different. that's the reason why using the existing capabilities and resources is the appropriate and the right thing to do. that's why our level of confidence is very significant. of course extreme of that, in terms of discovering, developing, manufacturing the vaccine it's been dramatically faster, but again not by cutting any corners. but rather by using judgment in terms of which vaccines to go after and how to test them and running everything, and taking the financial and operational risk but not any -- cutting any corners. up to now it's been roductive. general perna: the other diff

slaoui said. will be last 5 million delivered the first week of january. then, you know, uptake from there. so, really i think strong message in that we're getting the vaccines out as fast as they are available. thank you. >> thank you. and our next question here will come from candace troy. your line is now open. >> hi. dr. slaoui, can you clarify what is being explored for them but the moderna dosage. is it possible that people will only be given one dose? is that being explored for pfizer as well? dr. slaoui: [indiscernible] vaccine is totally inappropriate at this stage. why? because the data -- two doses. we know the second dose increases the strength of the immune response in terms of antibody response. we know the memory is installed much in a stronger way after the second dose. firstesigned to learn the time it sees an antigen and to really burst when it's -- it is exactly when we get -- [audio static] [indiscernible] when we get a booster. every five years. that is how it is designed to work. a one doseassuming strategy with something like think s

slaoui just talked about. so half the allocation will be sent out, then for pfizer, then for moderna, we send out the second half of allocations. two reasons. one, to ensure we don't overadminister, and that we have the second dose on hand. and second reason is to make sure that we don't overwhelm limited storage capability and capacity at the state level. we want to augment their plans, enable their plans, not constrain them from the greatest distribution capability that they have. we utilize a tiberius platform that we developed, right, which is a capability that takes in all the informative data from the states, hospitals, doctors' offices, pharmacies, only on the specification of vaccine as it is delivered and vaccine as it is administered so that we can maintain the flow of vaccine to the american people. as i've talked about, our goal is to distribute within 24 hours after eua. and the first push is, then we want to maintain a cadence, a deliberate, planned, coordinated cadence of delivery of vaccine as

with that i'll have things over to doctor slaoui for a scientific review. >> thank you mister secretary. briefly first of course this past week the approval of the moderna vaccine by the fda after i think a rich discussion review by the brook act as you could see i hope you have the chance to attend not all of those conversations, efficacy and safety were frankly overwhelmingly positive. so was the positive votes. the only point of discussion that took place in regard of what to do for the placebo recipients and the trials. should they be kept on placebos? should there be provided vaccines on the basis of priority populations as vaccines in the general population or should they be offered vaccine? what's at stake is how much more information can we extract from a placebo controlled part of the trial versus a non-placebo part of the trial. i'd be happy to address any questions in that regard . there's also the start of a trial in the population age 12 through 18 to enhance the population and because of the population emergence of the vaccine there's considerations on those trials to see

moncef slaoui joins us from just outside of philadelphia. good morning. >> good morning. >> brennan: people hear a vaccine is on the horizon and they may let down their guard over the next few weeks. how long before be could see a vaccine have an impact on lowering infections? >> doctor: well, i think we may start to see some impact on the most susceptible people probably in the month of january and february, but on a population basis, for our lives to start getting back to normal, we're talking about april or may. and, therefore, it is absolutely vital that everybody (a) takes comfort in the fact that we have light at the end of the tunnel and find the energy in that to continue to wear our masks, distance ourselves, wash our hands, pay attention to what we're doing to make sure we are there by the spring to benefit from the vaccine. >> brennan: thank you for that. when it comes to actually delivering shots in the arms, russia and theu.k. are about to begin that in the next few days. the u.s. still has not approved its vaccine, the first in

slaoui, real quick before you go.he potential of another pandemic being hurled at us? >> so i hope -- i hope we will take our lessons from this one and go from reacting, which we did very well, but it's been very, very expensive and very demanding on all the parties involved. we move from a reactive approach to a proactive approach, where by we may set up a permanent organization that may be somewhat similar to what the operation has been but that has access to manufacturing capacity, has access to laboratories, has access to platform technologies that can be on an ongoing basis preparing vaccines against known potential agents that can be pandemic so that if there is a pandemic with one of those agents, we can immediately have a vaccine or at least have an organization that's ready to run with all the infrastructure and the experience needed to go even faster than we have done this time. maria: well, we'll see if we have any plans in place. that means partly we need to move the manufacturing facilities out of china a

moncef slaoui. thank you for joining me. i don't want to put you in a position you have to respond to a phone call between mark medicines do medicine dose and dr. hahn from the fda. i don't want to put you in an awkward position. but i want to ask this question. are you concerned that this story that the white house is pressuring the fda could undermine confidence in a vaccine that you feel very positive about? >> yes, i think there is an important opportunity there for people to see undue pressure if the story is right. i just heard before this that dr. hahn said it wasn't a true reproduction of what happened. i can say because i watched all of the events yesterday is that it was an outstanding set of discussion, presentations by the fda, presentation by pfizer, the discussion that the advisory committee had. they really honed on very important questions around the age or so around potentially the people that have very severe allergies and the country for the whole day see that this was an effective transparent thorough in-

slaoui gave a lower number of 14 million. which is the right number and if it went down can you please explain why? >> i explained that 20 million people would be immunized, ways say that come in the month of december befe the end ofhe year. not sure about the 14 million. a be the 14 billion isctually the order of magnitude of number of doses can -- 14 million -- between the two tha we enough vaccine doses to vaccine 20 million people in the month of decemr and give them a second dose in the month of january and immunize an additional 13 million people in the month of genuine. >> such as to be clear with all three of us sitting here. byhe end of december we believe the would be enough vaccine distributed to get a first dose vaccination for 20 million people. then as dr. slaoui just said by the end of january to add another 30,000,001st dose vaccinations. and then by the end of february we actually believe we could have 100 million vaccines shots in arms that will of been done tween first dose and booster shot vacnations of in

nationwide and frankly around the world and today we got a chance to talk to doctor slaoui who is the director of operation warp speed about some of those challenges. >>things happen and when they happen. it would be ready to do with them just spent about doctor moncef slaoui chief scientific adviser for operation warp speed says developing covid vaccines in under a year. >>was a monumental task now he says distributing those vaccines may be just as difficult we are working the streaming hot to avoid. >>the inevitable challenges and you its come as we start to execute doctor slaoui says it's hard to anticipate what those inevitable hurdles will be he tells news nation. the white house coronavirus task force has run rehearsals with states to try to prepare different states are in different of preparedness as we speak states will be ultimately the deciders about who fits into those different categories and how to prioritize and actually get vaccine to individuals crafter josh, show with the kaiser family foundation says rural states with fewer hospitals and care centers. >>may have a to

slaoui noted but give us a very nice size safety database. although normally we like to have longer follow up of individuals perhaps than we'll have right now, we're able to make up for that by following the people who are in the clinical trials for longer periods of time and by the fact that over the past ten years in the united states, we developed a very robust safety surveillance system which uses large databases during hundreds of millions of live to look at adverse events to make sure there are not problems coming up after the vaccines are given to people. we wouldn't let them out there in the first place if we thought that there was any significant chance of that. but we are going to make sure by monitoring them that there are things that emerge as they're used. >> what happens next? i know obviously the fda will go through their process. a lot of people are expecting -- we hope for authorization. so assuming that that happens, assuming that you issued the eua, what happens next? >> so after an emergency use authorization is granted, w

slaoui, thank you so much. big game later today against the cardinals. >>> time is money, jobs and food on the table, time is running out. congress made a breakthrough overnight, will there be a deal today? republican senator mitt romney joins me next. >>> and they have a history on the campaign trail, will they now make history as teammates? biden's transportation pick pete buttigieg joins me exclusively in moments. when i was laid off... ...it was absolutely terrifying. i felt like i was just fighting an uphill battle in my career. as a little kid i knew that i wanted to work with computers. ♪ so when i heard about the applied digital skills courses, that definitely appealed to me. you're learning how to create spreadsheets, documents, forms and surveys. i'm thinking i can become more marketable. i got to about the third course and i'm like, you know, i probably could do this for a living. you don't need to be a computer expert to be great at this. these are skills lots and lots of people can learn. ♪ i feel

slaoui says it could be approved in april. admiral brett giroir, part of the white house task force, says it's the hhs secretary who serves on the task force who was on with me yesterday, he defended the vaccine rollout, saying it was really up to the states. >> the federal plan is to provide the guidance, to provide the infrastructure. you know, we're providing all the vaccines, the distribution mechanisms, the needles, the alcohol swabs. it's really a state and local level to get vaccines in arms like it always is, every year, 170 flu shots. that's done at the local level. the federal government doesn't invade texas or montana and provide shots to people. >> dr. adalja, any reaction to that? >> i wouldn't take a victory lap over this if these are vaccines that are just sitting in refrigerators. there's a big difference between a vaccine and a vaccination program. if they're not getting into people's arms, they're worthless. there's zero efficacy to a vaccine that isn't used. this isn't the time to shift responsibility to the

moncef slaoui explain they didn't know that the vaccine was going to be as good as it was. do you consider this to be an understandable decision or was this a big mistake? >> well, it does seem the rational that dr. moncef slaoui and others have given as well were twofold. at the time they were making bets. they weren't certain which of these vaccines was actually going to, you know, get through phase three clinical trials and actually start to be able to show benefit. also, from what i understand, hhs just put out a twitter threat about this saying they didn't have confirmation that they could have deliverable vaccine on a timetable they wanted from pfizer and that is part of the reason they say at least they didn't go ahead and make those orders. one thing let me show the other vaccines to give you some context here. there were a lot of bets made on various vaccines. oxford astrazeneca, 300 million doses essentially purchased. you can tell when you look back where they thought they were most likely going to see success. we say astrazeneca and johnson & johnson second from

slaoui said to be careful in case of manufacturing issues. do you think that was the right call? push out as much vaccine as possible. you have to take a little bit of a risk that the supply is going to be there in 2021, to give everyone a second dose. this is a crisis, we need to get as many vaccines as possible in arms, in my view. you might want to hold a little in reserve, but not much. the first dose is partially protective, probably. the data does suggest that. i think we want to spread as much vaccine as possible. if we can't get two people whto peoplewho get their first e the second dose in 2021, we'll have much bigger problems. so we need to take a bit of a risk. >> brennan: scientists at the university of washington estimate that vaccines will save 9,000 lives before april, and 14,000 more could be saved if there is a scale-up among high-risk individuals. what does a more aggressive push look like? >> doctor: the supply will ramp as we get into 2021, but there is no way to accelerate that between now and say march. if you want to maximize preservation of life, you vacci

moncef slaoui the trump administration's chief adviser for vaccine development-- operation warp speed-- said he expects an approva >> it should take them about 2 hours to make it to the various immunization sites that the various jurisdiction and states have told us to ship vaccines to them and within, i would say, 36 hours from approval, potentially the first immunization could be taking place. >> sreenivasan: slaoui also said will have his first meeting wito president-elecbiden this we. on fday mr. biden said he had nfo yet seen a detailed pla vaccine distribution. across the country, the virus continues to resurge. spitalizations, confirme cases and deaths related to covid-19 are all increasing. dr. deborah birx, the white house coronavirus response coordinator, cautioned americans to continue to take actions to slow the spread of the coravirus and not to believe >>lse information. hear community members parroting back those situations, parroting back that masks don't work, parroting back that we should work towards herd immunity, parroting back that gatherings don't result in supe

even moncef slaoui asked some questions about that. there's also this larger question of the "new york times" story that is out today indicating that the united states government apparently passed on hundreds of millions of doses of vaccine from pfizer back about july or august, in that time frame. kayleigh mcenany the white house press secretary was out on the driveway and i asked her about that. she flatly denied t she says the united states government didn't pass on anything. but we are told that there are negotiations continuing with pfizer and the other companies. yesterday there was a conference call with senior administration officials and they gave a little bit of the back story, again, denying "the new york times" report and they said essentially that anybody who wanted to sell a guarantee of hundreds of millions of doses of vaccine without an emergency use authorization was just not going to get the government's money. dr. slaoui talked about that, too, if we have that sound bite. do we? >> let me remind everybody what our st

doctor slaoui says even as a vaccine begins to go out it's important to stay vigilant, we're still going to be a long way from being out of the woods even has its end distribution so the answer is yes because we are. >>not a overnights to immunize the guys here or position in the u.s. it is very important we are patient and resilient and get to the very end of the tenant. >>but doctors always says that there is light at the end of that total in the form of this vaccine and he says that by the summer time. he hopes the vaccine will be successful. it will be distributed to the general public and he says next summer hopefully will not look anything like this previous one dead. in washington joe khaleel. >>the department of defense released the first images of a covid-19 vaccine record core our record card and vaccination kids so everyone will be issued a red card you can actually putting your wallet. it will tell what they need to know what they had when their next doses do as well the cdc says of the vaccine will be administered in 2 doses separated by 21 to 28 days and that's because diff

moncef slaoui next and backfiring?resident trump continuing to spread lies as he campaigns in georgia. >> if you don't vote, the socialist and is the communists win. >> but will his mixed messages fire up the base or convince them that voting isn't worth it? i'll speak to georgia lieutenant governor geoff duncan in moments. >>> congress works to pass another stimulus bill as americans are desperate for economic aid. >> it would be stupidity on steroids if congress left before christmas without doing an interim package. >> one of the senators negotiating the compromise bill, mark warner, and congresswoman karen bass join me to discuss ahead. >>> hello, i'm jake tapper in washington where the state of our union is suffering. the united states is now in the worst stretch of the pandemic by far between 2,000 and 3,000 deaths every day, setting horrible records in daily at the times, hospitalizations and new cases and we have not started to see the thanksgiving effect on the numbers yet as hospitals begin to max out and run

moncef slaoui next. >>> back firing?rump continues to spread lies as he campaigns in georgia. >> if you don't vote the communist and the socialist win but will he mix up the base and voting isn't worth it? i'll speak to the georgia lieutenant governor geoff duncan in motor. >>> congress works to pass another stimulus bill as americans are desperate for economic aid. >> it would be steroids for congress if they left without an intimidate package. >> will new hope turn into actual help this time? one of the senators negotiating the compromise bill mark warner and congresswoman karen bass join me to discuss ahead. ♪ >>> hello. i'm jake tapper in washington. the united states is now in the worst stretch of the pandemic by far between 2,000 and 3,000 deaths every single day and setting horrible records in number of daily deaths and in hospitalizations and in new cases and we have not even started to see the thanksgiving effect on the numbers yet as hospitals begin to max out and run out of icu beds and medical workers are ple

moncef slaoui. thank you for joining us.hat are you seeing in the data that was released this morning? >> seeing a good vaccine with 94.5% efficacy against disease. there were 30 cases of severe disease in the control group, no cases in the vaccine group. excellent efficacy in the higher age group, over 65. similar efficacy in the more diverse population, which is a combined group of african-american and hispanics and native americans. really across the line very good efficacy. for those who will be looking more in detail into the data, actually also excellent onset of efficacy after the first dose, more or less ten days after the first dose. again, 90% protection going forward. so really a performance that's similar to that of the pfizer vaccine. and safety that's also similar to that of the pfizer vaccine. no serious adverse events of any concern. all of them are associated with the injection site or like a little bit a fever, a little bit of chills and muscle ache for about 24 to 36 hours after immunization in maybe 15, 2

>>the inevitable challenges and you it's come as we start to execute doctor slaoui says it's hard to anticipate what those inevitable hurdles will be he tells news nation. the white house coronavirus task force has run rehearsals with states to try to prepare different states are in different of preparedness as we speak states will be ultimately the deciders about who fits into those different categories and how to prioritize and actually get vaccine to individuals copter josh, show with the kaiser family foundation says rural states with fewer hospitals and care centers. >>may have a tougher time getting the vaccines to vulnerable populations and medical workers both of whom are first priority some states will be much more ready to get the vaccine out there in the quick efficient way another challenge me showed says making sure those who received their first dose come back for a second both moderna and pfizer's vaccines require 2 shots that is a significant logistical challenge to track all these individuals will be making might be moving around the congressman and physician doctor

moncef slaoui is the chief scientific officer for the government's vaccine and erapies program, knownperation warp speed. he joins me now. . slaoui, very good to have you on the "newshour". 100 million americans by the end of february, that seems a o remarkabtimistic and ambitious goal. >> well, it is an ambitious's goal, and goal that we have been working very hard since the month of may to be able to achieve, frankly. we are, as you know, on the verge of having two vaccines approved, i hope, by the f.d.a., on decembe or so and can start immunizing.and we we think we will have 40 million doses of this vaccines in the month of december, that's enough to immunize 20 million people because each individual needs tw of the vaccines. and we plan to have about 60 million doses ie month of january, and then 100 million doses between these tw vaccines in the month of february. and we feel that the plan is achievable. it's stretched, it's challenging, but it's. achievab >> reporter: it is rmarkn't we're even talking about vaccines being deveand rolled out in the same year we discovered the vir

slaoui, thank you again. people are very grateful, of course, for the progress so far, and the anticipation of more progress to come. thanks for being with us today. >> thank you for having me. >> you bet. >>> and the number of people who are hungry in this country is staggering. the crisis exacerbated by the pandemic. more than 50 million americans will not have enough to eat this year, potentially including 17 million children. today msnbc is joining nbc news on all of our programming to highlight work being done around the country to combat the crisis in food insecurity, intensified by the pandemic. one organization that started fighting this problem right away in march is world central kitchen. it's already provided more than 33 million meals in more than 400 cities. joining me now is chef jose andr andres, founder of world central kitchen and the chef and owner of the food group. thank you for being with us, chef. as you know well, this national hunger crisis is so exacerbated because of covid. what are

moncef slaoui of operation warp speed defended the move on "gma" saying they were spending money on six vaccines and not ready to invest more in pfizer. >> now in the summer, if somebody came to us and said, let's buy more of this vaccine or that vaccine, no one reasonably would buy more from any one of those vaccines because we didn't know which one would work. >> and coming up at 7:00 on "gma" what dr. slaoui says should be done about a supply chain issue that could slow production. >>> coming up on monday a special edition of "20/20." that is monday night at 10:00 right here on abc7. >>> today health and human services secretary dr. mark ghaly will give an update on the state's response to covid-19. last week dr. ghaly said californians should not be traveling. he encouraged people to cancel nonessential travel plans and stream the update on our app and on abc7news.com. >>> more than 10,000 people are hospitalized due to coronavirus in california and more than 2,300 in the icu and 24,000 new cases were reported yesterday and that is the third highest single day total. here in the bay

slaoui said they expect an emergency authorization fairly expectly. dr. slaoui expects the vaccine in the arms of people in the next couple weeks. and that is short, though of the hundreds of millions that the doctor said he hoped they could achieve at the end of the year when he took on this position last summer. let's listen to him talking about some of the challenges they face. >> actually, the goal was barely achievable. i describe it as credible, but incredibly challenging to achieve it. the hardest, frankly, was to identify the vaccine, do the phase three ask scale up. on the manufacturing side, it turned out to be more complicated than we planned. we are probably six or eight weeks later than an ideal scenario, where we would have had a million doses by the end of the this year. >> reporter: he says he believes they are about six to eight weeks behind, but nonetheless stressing this is not just simple mathematics, not simple manufacturing there have been some glitching, but nonetheless, some vaccines he hopes could go into arms by the end of this w

monoreceive sl -- moncef slaoui.ions and answers to get from that discussion in just a little bit. you're watching "squawk box" here on cnbc get real-time insights in your customized view of the market. it's smarter trading technology for smarter trading decisions. fidelity. don't settle for silver #1 for diabetic dry skin* #1 for psoriasis symptom relief* and #1 for eczema symptom relief* gold bond champion your skin gold bond it's different because i have to talk to a computer. i get like 6 emails a day... olivia please turn your screen on. okay, lift the... there you go. mondays remote, tuesdays at school... it's the other way around. we might not be able to solve everything. but we can help make sure students and teachers can stay connected to learning. it's why at&t has connected more than 200 million students to brighter futures. >>> this week could give congress the last best chance to pass another round of economic stimulus before some of the key benefits run out ylan mui joins us with the latest out of washi

moncef slaoui, said once the vaccine or vaccines are out there, the number of doses will vary week by week. listen here. >> unfortunately the mathematics are misleading. the numbers we share with you are monthly numbers. 40 million this month, 50 million next month. that is not how life happens. the life happens 40 million this month. two million this week, five million next week, three million the week after, seven million the week of a port port slaoui, connell, was optimistic about johnson & johnson vaccine candidate. we might learn the result at the very beginning of next month, connell. connell: blake burman at the north lawn off the white house. overseas on the second day of the uk's vaccine rollout. officials warning that people with significant history of allergic reactions should not be given the pfizer biontech shot. after two health care workers experienced adverse reaction to it. u.s. officials are seeing first effects of thanksgiving travel. more than 200,000 americans are testing positive for coronavirus every day on average. hospitalizations at record levels. third day

they'll meet thursday with moncef slaoui from operation warp speed, but they're not being included at all in this big white house summit today. >> that's right. and we expect that president-elect joe biden will be naming xavier becerra, attorney general for california, as his hhs secretary. he will undoubtedly key to the effort to get the vaccine out. he would be the first latino to serve in that role if in fact confirmed. but you're absolutely right, andrea, what's critical here is that the biden team has a plan to roll this out, that they are in communication with the folks at operation warp speed. now, biden has said that despite the fact that there was that delay initially in having communication with the trump administration, with officials at operation warp speed, he feels confident that they will be able to make up for lost time. but as you know, andrea, part of this is going to be trying to instill trust in this vaccine with nearly 40% of americans saying they're not going to take it, that they don't have faith in the vaccine. and so this is going to be an uphill battle. the b

moncef slaoui, the head of operation warp speed expecting emergency authorization for pfizer's vaccine is imminent, and hopes that it will be available, perhaps, later this week. >> the vaccine is safe. its safety profile is comparable to many other vaccines that have been in use for years. >> still, important questions are unanswered, like how long immunity lasts after a vaccination, and can you still infect someone else even if you're protected. a pugh study finds 60% of americans would take a vaccine if it were available today, but that's still short of the 70 to 75% that dr. anthony fauci says is needed to get the country on the road to normalcy. >> yeah, and relief remains some time off for most americans, including californians. the state reported more than 30,000 new cases on sunday alone. cnn's paul vercammen has more from los angeles. >> reporter: laura, boris, you alluded to it, the number just horrific and heartbreaking and record shattering in california. all of these cases and hospitalizations, the new orders to go into effect. one of those orders shuts down outdoor dining

slaoui says more information is needed on the adverse reactions. >> it is superior to what one wouldxpect with other vaccines. we would have expected in the range of maybe 1 person having an allergic reaction, with the pfizer vaccine. >> now to the united kingdom where officials are imposing travel restrictions with south africa after finding another coronavirus variant even more tra transmissible than the one recently discovered in england. the tense waiting game at the english port of dover is stretching into another day, and frustrations are boiling over. thousands of truck drivers are scrambling to get covid tests so they can cross into france now that it's eased travel restrictions with the u.k. cnn's salma abdelaziz joins us from dover to explain the chaos. good to see you. so the travel restrictions may have eased but the test has been slow, hasn't it, what is the latest on this. >> reporter: after a very tense day yesterday, we finally saw testing start just at about dusk, really. but i know you have pictures there to show of just how the day unfolded. what really happened he

moncef slaoui joins me.isgraced former michael flynn to force a new election in states that trump lost. how scared can we be? republican senator mitt romney and pete buttigieg is joining us. >> plus, act of war? the u.s. scrambles to a sweeping cyber attack linked to russia. >> this is a major hack of our national infrastructure sector. >> reporter: why is president trump blaming someone other than putin? i'll speak with chris krebs. >>> hello. i'm jake tapper in washington. what an outgoing president can do in the final month of an office we are getting something of a an idea. flynn's proposal to declare martial law. trump is talking about giving the powers of a special counsel to attorney sidney powell whose crackpot conspiracies have been laughed courtroom after courtroom. and trump's attorney rudy giuliani has been asking officials of the department of homeland security about seizing voting machines. this as the united states suffered what experts are describing as a modern day cyber equivalent of pearl

moncef slaoui said there have been no major logistical issues and called it heart warming and promising to see people getting the first shots. >> up to now it's going frankly very well. to all 636 locations that we had distribution has now taken place to all 636 locations that we had identifiedd arise of the we've heard so much about how th >> now two wrinkles did arise, we've heard so much about how the pfizer/biontech vaccine has to be kept so cold two boxes got too cold and had to be replaced had they're studying those doses to see if they can still be used. the other wrinkle, hospitals found once they dilute they dile vaccine, there may be more doses per vial than they thought confusion over the issue led some hospitals to discard one in six doses. that's according to reporting from stat news but it also means there might be slightly more supply of this vaccine than we thought, so gos doctor maybe some good news doctor slaoui called the efficacy of pfizer and moderna's vaccines impressive. the panel will vote in the afternoon and the fda is expected to give authorization friday or s

slaoui is the head of "operation warp speed." already been evidence of daylight between the two sides on how much the biden team believes there has been a plan in place to not just get a vaccine manufactured and sent to the states but then from that point forward, from the states into as biden says, into arms from vaccinations, from vaccine to vaccination. that's going to be a critical conversation that happens this week. the delay in the transition really did set back the biden team and really understanding fully what position we're in to get that vaccine out to the public. of course, we expect that some time next summer. i also want to mention something you'll be talking about later as well and that's biden's choice for defense secretary. there is a pandemic related part of this. one of the reasons we understand why joe biden selected lloyd austin to be his pentagon secretary, given his experience as a retired general is that the military plays a role in all of this. expect to see that announcement potentially on paper today as

but moncef slaoui, the chief science adviser for "operation warp speed" doesn't know anything about thisxecutive order and there are questions about the logistics involved in distributing the vaccine and new concerns about when doses will be available. according to "the washington post," pfizer has told the trump administration it cannot supply an additional 100 million doses of vaccines until late june or july because other countries have already bought most of its supply. "the new york times" is reporting that the administration passed on a chance to secure more of the pfizer vaccine. the report essentially confirmed this morning by the former fda commissioner and current pfizer board member scott gottlieb. >> pfizer did offer an additional allotment coming out of that plant. basically the second quarter allotment to the united states government multiple times. and as recently as after the interim data came out and we knew this vaccine looked to be effective. i think they are betting that more than one vaccine is going to get authorized and there will be more vaccines on the market and

moncef slaoui and pete buttigieg, senator mitt romney, and ex-security czar christopher krebs.morning with us. really fast. really perfect. let's end the year nailing it. ♪ but i'm not a new customer. leta deal on a smartphone, it. well, actually now, new and existing customers can get our best smartphone deal. it's historic. that is historic. which means... i'm making history, right? yea, i don't know if i'd exactly sa- wow. me, dave brown. existing customer who got the greatest deal in history. just like every other customer gets... oh that's cool too. it's not complicated. at&t is making history. everyone gets our best smartphone deals. bibill assumed his mayo was the best choice. assume nothing. just like the leading brand, kraft real mayo is made with high quality ingredients at a price you can feel good about. no wonder kraft is so good. ♪ >>> dose of hope. as the fda approves a second coronavirus vaccine, americans line up. >> history will record that this week, was the beginning of the ends of the coronavirus pandemic. >> as cases, hospitalizations and deaths climb to r

it would be ready to do with them just spent about its doctor moncef slaoui chief scientific adviser for operation warp speed says developing covid vaccines in under a year. >>was a monumental task now he says distributing those vaccines may be just as difficult we are working the streaming hot to avoid. >>the inevitable challenges and you learning since come as we start to execute sku doctors allawi says it's hard to anticipate what those inevitable hurdles will be he tells news nation. the white house coronavirus task force has run rehearsals with states to try to prepare different states are in different levels of preparedness as we speak states will be ultimately the deciders about who fits into those different categories and how to prioritize and actually get vaccine to individuals copter josh, show with the kaiser family foundation says rural states with fewer hospitals and care centers. >>may have a tougher time getting the vaccines to vulnerable populations and medical workers both of whom are first priority some states will be much more ready to get the vaccine out there in